411
Participants
Start Date
April 5, 2023
Primary Completion Date
January 31, 2027
Study Completion Date
June 30, 2027
BCD-217
BCD-217 (anti-CTLA4 agent nurulimab + anti-PD1) once every 3 weeks in the neoadjuvant setting
anti-PD1
anti-PD1 agent in the adjuvant setting
Excision of the primary lesion
Excision of the primary lesion will be performed per standard of care.
Regional lymphadenectomy
Regional lymphadenectomy will be performed per standard of care.
Regional Clinical Oncology Hospital, Yaroslavl
"Regional Goverment Budgetary Healthcare State Kostroma Oncology Center", Kostroma
"JSC Modern Medical Technologies", Saint Petersburg
Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), Saint Petersburg
"Healthcare Institution Minsk City Clinical Cancer Center", Minsk
Clinical Oncologic Dispensary No. 1, Krasnodar
Clinical Oncologic Dispensary No. 2, Sochi
"State Budgetary Healthcare Institution Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine,", Chelyabinsk
"Nizhny Novgorod Region State Budgetary Healthcare Facility Clinical Diagnostics Center", Nizhny Novgorod
"State Institution Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov", Lesnoy
"State Institution Mogilev Regional Oncological Dispensary", Mogilev
"Healthcare Institution Vitebsk Regional Clinical Oncology Center", Vitebsk
State budgetary healthcare institution Leningrad Regional Clinical Hospital, Gatchina
"State Autonomous Health Institution Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal", Kazan'
"State budgetary health care institution Kuzbass clinical oncological dispensary named after M.S. Rappoport", Kemerovo
"State Budgetary Institution of Healthcare Leningrad Regional Clinical Oncological Dispensary named after V.I. L.D. Romana", Kuz'molovskiy
"Russian Cancer Research Center named after N.N. Blokhin of the Ministry of Health of the Russian Federation", Moscow
Branch of Hadassah Medical LTD Limited Liability Company, Moscow
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow
"Joint Stock Company K31 City", Moscow
"JSC Medsi Group", Moscow
Moscow City Oncology Hospital No. 62, Moscow
"State budgetary health care institution of the city of Moscow City Clinical Oncology Hospital No. 1 of the Department of Health of the City of Moscow", Moscow
"LLC DobroMed", Novosibirsk
"State Budgetary Healthcare Institution Novosibirsk Regional Clinical Oncology Center of the Novosibirsk Region", Novosibirsk
"Federal State Budgetary Institution National Medical Research Center for Radiology of the Ministry of Health of the Russian Federation", Obninsk
"Budgetary healthcare institution of the Omsk region Clinical oncological dispensary", Omsk
City Hospital #40, Kurortny district, Saint Petersburg
"Federal State Budgetary Educational Institution of Higher Education Saint Petersburg State University", Saint Petersburg
"Limited Liability Company American Medical Clinic", Saint Petersburg
"Limited Liability Company Oncological Research Center", Saint Petersburg
"Limited Liability Company Strategic Medical Systems", Saint Petersburg
N.N. Petrov National Medicine Research Center of oncology, Saint Petersburg
Private Medical Institution Evromedservis, Saint Petersburg
"Federal State Educational Institution of Higher Professional Education Mordovia State University N.P. Ogareva ", Saransk
"State Health Care Institution Volgograd Regional Clinical Oncology Dispensary № 1", Volgograd
Lead Sponsor
Biocad
INDUSTRY